Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008124 |
---|---|
Receipt number | R000009565 |
Scientific Title | Phase II study of Pemetrexed and Bevacizumab in Performance status 2 patients with advanced non-squamous non-small cell lung cancer. |
Date of disclosure of the study information | 2012/06/08 |
Last modified on | 2018/06/14 10:42:37 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/06/08 09:53:35 | ||
2 | Update | 2014/02/17 14:47:49 | Key inclusion criteria Key exclusion criteria |
|
3 | Update | 2014/05/21 13:55:54 | Email Name of person sending information Name of person sending information Organization Address Address |
|
4 | Update | 2015/05/29 14:01:52 | Division name Division name |
|
5 | Update | 2016/05/12 10:07:40 | Name of person sending information Name of person sending information Division name Division name TEL Name of primary person or sponsor Organization |
|
6 | Update | 2018/06/14 10:42:37 | Name of person sending information Name of person sending information TEL |